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Shortly after it was found that influenza viruses are capable of agglutinating 
chicken erythrocytes (1),  it was shown that serum from normal ferrets inhib- 
its such hemagglutination (2).  Similar inhibition was obtained with serum from 
other animal species as well as with a variety of tissue suspensions (3-11). In ad- 
dition, it was found (15) that after adsorption of influenza virus on erythrocytes 
spontaneous elution of the agent takes place and is accompanied by loss of the 
capacity of the erythrocytes to adsorb more virus. Subsequently, it was demon- 
strated that erythrocytes which had been treated with influenza virus have an 
electrophoretic mobility lower than that of untreated red blood cells  (12-14). 
However, the properties of the eluted virus appeared to be unchanged (15). It 
was also shown that influenza viruses are capable of inactivating the inhibitory 
components derived from tissues (16, 17). After heating the virus at 56°C., the 
agent does not elute from erythrocytes and fails to inactivate inhibitory com- 
ponents  (18-20).  Moreover, virus so heated shows an increased susceptibility 
to inhibitors of hemagglutination (21). 
The present view is that influenza viruses as well as mumps and Newcastle 
disease viruses are capable of altering enzymatically the structure of the surface 
of red blood cells and possess similar activity against inhibitors of hemaggluti- 
nation. As a  result of such viral action, the capacity of red blood cells  or of 
inhibitory components to combine with these agents is lost. This concept was 
proposed  originally by Hirst  (2). 
Several attempts to isolate, purify, and identify inhibitory components have 
yielded  substances  of high  activity,  but  each  has  contained non-inhibitory 
contaminants (22, 23). In these investigations egg white was used as the starting 
material.  In  other  less  extensive  studies  various  materials  have  been  used 
including serum or plasma (4, 24, 25), erythrocytes (9, 26), and cow's milk (27). 
The present study was undertaken because of interest in the enzymatic ac- 
tivity associated with influenza, mumps, and Newcastle disease viruses,  and 
because  the interaction between these agents and erythrocytes or inhibitory 
components may be  analogous to  certain phases  of the  interaction between 
viruses and susceptible host cells.  Interest in the enzymatic activity of these 
71 72  MUCOPROTEINWHICHREACTS WITH VIRUSES 
viruses derives from present ignorafice of the mechanisms available to viruses 
during interaction with  their environment, particularly during  the  process of 
multiplication. When the effects of viruses on the metabolic processes of host 
cells are considered,  two hypothetical mechanisms appear to merit attention: 
the first involves effects mediated through viral enzymes; the second involves 
effects determined by genetic units  of viruses but mediated through enzymes 
of the host cells. The analogy between the interactions of viruses with erythro- 
cytes or hemagglutination  inhibitors  and  host  cells stems from the  following 
observations: Influenza viruses adsorb on and elute from surviving or dead host 
cells in a manner similar to their interaction with red blood cells (28). Extracts 
of Vibrio cholerae abolish the capacity of erythrocytes,  inhibitory components, 
and host cells to combine with viruses (17,  29, 30). Treatment of chick embryos 
or  mice  with  such  extracts  renders  these  hosts  temporarily  less  susceptible 
to influenza virus infection (31,  32). 
In a previous communication (33)  the inhibitory properties of normal human 
urine with respect to certain viruses were described and isolation of a mucopro- 
tein responsible for the inhibitory capacity was reported. The presence in hu- 
man urine of a highly active inhibitor of viral hemagglutination makes available 
an abundant source of this substance and  one essentially free of proteins. Fur- 
ther work was carried out in the hope that the urinary mucoprotein might yield 
a  single substance which would serve as a  substrate for influenza viruses. 
In this  communication procedures for isolation  and  purification of urinary 
mucoproteins are  described.  It is  shown  that  on purification  a  highly  active 
compound is obtained which  appears on  the basis of physicochemical studies 
(34,  35)  to be a  single homogeneous substance.  The substance appears to be 
mucoprotein in nature. A number of the biological, chemical, and physicochemi- 
cal properties of this mucoprotein are presented.  Certain features of the inter- 
action between the substance and influenza, mumps, or Newcastle disease virus 
are demonstrated. The quantitative relationships and the kinetics of the inter- 
action are delineated, and various b~logical and physicochemical properties of 
the mucoprotein altered by viral action are described. 
Materials and Methods 
Urinary Mucoproteins.--The term urinary mucoprotelns applies to the material isolated 
from human urine by precipitation with sodium chloride under the conditions described  below. 
The term inhibitory mucoprotein is used to designate a homogeneous component of urinary 
mucoproteins which is soluble in phosphate buffer. In most experiments solutions of muco- 
protein in 0.025 ~ phosphate buffer at pH 6.8 were  used. Solutions were  prepared by dissolving 
frozen and dried mucoproteins. Because the substance dissolved slowly, it was usually neces- 
sary to hold the material for 16 hours at 4°C. and 8 hours at 25°C. The solutions were then 
centrifuged at 3,800 g for 30 minutes, the supernatants  collected, and the concentration of 
mucoprotein was determined spectrophotometrically. 
Viruses.--Lee, MB  (influenza B virus strain isolated in 1950; third  egg passage), PR8, 
FM1  (llth egg passage), NA and RA (influenza A virus strains isolated in 1951; NA: 2nd I. TAMM AND  i~. L.  HORSFALL~  JR.  73 
and 7th egg passages; RA: 1st and 5th egg passages), swine, mumps, and Newcastle disease 
viruses were used. Each virus was inoculated into the allantoic sac of 10 day chick embryos 
and allantoic fluid was harvested 48  hours later.  For most experiments allantoic fluid  was 
dialyzed against 80  volumes of 0.025  M phosphate buffer, and then centrifuged at 3,800  g 
for 10 minutes. The supernates were stored at 4°C. In some experiments infected allantoic 
fluid was not dialyzed but was centrifuged at 3,800  g for  10  minutes, and then stored at 
-65°C. 
V. cholerae Extract.--The Inabg strain of V. cholerae was grown at 37°C.  for 16  hours in 
neopeptone broth. The bacteria were then sedimented in the centrifuge and the supernate was 
filtered through a  Coors No. 2 candle. The filtrate was tested for sterility and for receptor- 
destroying enzyme (RDE) activity by the method of Stone (36). The filtrate was stored at 
4°C. between experiments. 
Red Blood Cdls.--Blood  from individual chickens was collected into ACD (37) and stored 
at 4°C. RBC were washed 3 times with 0.85 per cent NaC1 buffered at pH 7.2 with 0.01 
phosphate. In preparing a 1 per cent suspension, a photometric procedure was used to measure 
RBC concentration. 
Hemagglutination  Tests.--Serial  twofold dilutions of infected allantoic fluid  were made in 
0.4 ml. volumes of buffered saline and 0.4 ml. of RBC suspension was added to each tube 
(final  concentration --  0.5  per cent). Tests were read after 1 hour except when Newcastle 
disease virus was used in which case a 20 minute period was employed because of rapid dis- 
agglutination of RBC. The last tube showing strong agglutination (2 to 3+)  was considered 
as the end-point. 
Hemagglutination-Inhibition  Tests.--Serial  twofold  dilutions  of  inhibitory  mucoprotein 
or urine were made in 0.2 ml. volumes of buffered saline.  The dilution series was started with 
solutions containing not more than 100 #g. of mucoprotein per ml. With such concentrations 
good reproducibility of inhibition end-points was obtained. With higher concentrations the 
viscosity effect impaired the accuracy of twofold dilutions. Infected allantoic fluid,  diluted 
with buffered saline so as to yield a concentration equivalent to 4 or more hemagglutinating 
units of virus in the final mixture, was added in 0.2 ml. amount to each tube. In most cases 
the virus was heated at 56°C. for 30 minutes; in certain instances, as with swine, mumps, and 
NDV, other temperatures were used, and in some cases untreated virus was employed. The 
mixtures were kept at room temperature for 1 hour, then 0.4 ml. of 1 per cent RBC suspension 
was added and the tests were read after another hour. The dilution showing complete in- 
hibition of hemagglutination was taken as the end-point. The inhibition titers were expressed 
in terms of the amount of mucoprotein required for complete inhibition in micrograms per 
hemagglutinating unit  of  virus.  In  most instances inhibitory activity  against  Lee  virus, 
heated at 56°C. for 30 minutes, i.e., H. Lee, was determined. 
Enzymatic  Inactivation  Experiments.--Equal  volumes  of  mucoprotein  solution  and  in- 
fected allantoic fluid, at desired concentration, were mixed and held at 37°C. or at other tem- 
peratures as specified  below for various periods of time. The mixtures then were heated at 
65°C.  for 30 minutes to stop the reaction and to eliminate the virus. Hemagglutination-in- 
hibition titrations were then carried out with Lee virus which had been heated at 56°C. for 
30  minutes. When prolonged periods of incubation were employed, 1 to 2 drops of chloro- 
form per ml. were added to the reaction mixture. 
Infectivity  Titrations.--Serial  tenfold dilutions of virus were made in buffered saline and 
dilutions inoculated allantoically into groups of 10 day old chick embryos, 0.1 ml. per embryo. 
Eggs were incubated at 35°C.  for 48  hours. After chilling overnight at 4°C., the allantoic 
fluids were harvested and  tested for hemagglutinating ability.  E.I.50  (50  per cent embryo 
infectious end-point) was calculated in the usual manner. 
• Viscosity Determinations.--The  viscosity of mucoprotein solutions was measured in Ostwald 74  MIJCOPROTEIN WHICH REACTS WITH VIRUSES 
viscosimeters at 37°C, or at 200C. The viscosimeters were calibrated with distilled water as 
well as with 0.025 m phosphate buffer. In the calculation of the relative viscosity of a solution 
the calibration was chosen which corresponded to the solvent used. 
EXPERIMENTAL 
Precipitation of Mucoproteins from Urine wilt; Sodium Chloride.--The  striking 
effects of NaC1 concentration on the activity and solubility of the inhibitor in 
urine were reported previously (33).  Urinary mucoproteins were shown to be 
soluble in water but insoluble in solutions of NaC1 of moderate strength. This 
property facilitated the development of a  procedure for isolation and purifica- 
tion of the substances. 
A  more detailed study of  conditions under which precipitation of  urinary 
mucoproteins occurs was undertaken. It was found that at NaC1 concentrations 
as low as 0.07 M (i.e., one-half the physiological strength) reduced solubility of 
the  mucoproteins was  demonstrable.  However,  for  rapid  precipitation and 
maximal yield it was found to be desirable to use NaC1 in a  concentration of 
0.58 ~. Temperature and pH did not appear to be of critical importance within 
wide limits. 
The procedure used for the isolation of urinary mucoproteins was as follows: Urine was 
collected from normal men into sterile bottles.  Specimens were pooled and approximately 
30 ml. of chloroform was added per liter. Pools were stored at 4°C. and the isolation of the 
mucoprotein was carried out at the same temperature. The pH of pools of urine was usually 
in the range of 6.0-7.0. Pooled urine was diluted with an equal volume of distilled water to 
dissolve precipitates consisting mainly of urates and phosphates, To the diluted urine, sodium 
chloride was added to a concentration of 0.58 M. After relatively complete sedimentation of 
the white flocculent precipitate, the supernatant was siphoned off. A 0.58 z~ solution of NaC1 
was added to the sediment for preliminary washing and the precipitate was again allowed to 
settle. After removal of the second supernatant, the precipitate was collected by centrifuga- 
tion at 1900 R.~.M. for 30 minutes. Sediments were washed twice with 0.58 ~ NaC1 and sus- 
pended in distilled water.  Sodium chloride was removed by dialysis against approximately 
120 volumes of distilled water over a period of 4 to 5 days. The dialyzed solution was cen- 
trifuged at 7,000 R.P.~. for 30 minutes. The small amount of sediment obtained was washed 
once with distilled water and the washing was added to the first supernatant; the sediment 
was discarded. The final supernatant was concentrated by perevaporation and then frozen 
and dried. 
Two large pools of urine were used to prepare the mucoproteins employed in 
most of the experiments reported below. Table I  summarizes certain features 
of these preparations. The specific gravity and pH of the two pools were closely 
similar. Comparison of the yields of urinary mucoproteins and of the inhibitory 
activities indicates that the precipitation procedure gave reproducible results. 
Activity titrations showed that precipitation with sodium chloride under the 
conditions described above removed more than 99 per cent of the inhibitor from 
urine. The  sediment discarded  after  centrifugation of  the  dialyzed material 
contained less than 0.1 per cent of the inhibitor. When quantitative procedures I.  T#~  AND  F.  L.  ttORSFALL, JR.  75 
were employed throughout,  it was possible to obtain close to  100 per cent re- 
covery  of  the  inhibitory mucoprotein.  Serial titrations yielded no  indication 
that inactivation occurred during the process of isolation. 
Separation  of  the  Inhibitory  Mucoprotein  with  Phosphate  Buffer.--As  was 
stated above, urinary mueoproteins are soluble in water but not in NaC1 solu- 
tions  of  moderate  concentration.  For physicochemical  studies  as well  as  for 
interaction experiments with  viruses it was necessary to find buffer solutions 
in which the inhibitory component was soluble. 
Experiments showed that in 0.025 ~x phosphate buffer (ionic strength =  0.05) at pH 6.8, 
with mucoprotein concentrations  from 0.5 to 6.0 rag. per ml., 20 to 80 per cent of the material 
was soluble depending on temperature of solution and age of the dried preparation. Dried 
TABLE I 
Starting Material and  Yield for  Two Preparations of  Urinary Mucoproteins 
Urine, volume ................................ 
specific gravity  ......................... 
pa  ................................... 
Mucoprotein, yield, total ...................... 
yield/unit volume ................ 
activity*  ........................ 
Preparation A  Preparation B 
54 liters 
1.015 
6.13 
1.4 gm. 
0.025 gm./liter 
0.008 #g. 
135 liters 
1.015 
6.38 
3.2 gm. 
0.024 gm./liter 
0.012/~g. 
* Expressed as amount of mucoprotein required for complete inhibition in micrograms 
per hemagglutinating unit of heated Lee virus (56°C. for 30 minutes). 
mucoproteins  required 18 to 24 hours to dissolve in this buffer at 4°C. and the process was 
accelerated by intermittent shaking. The insoluble portion was separated in the centrifuge at 
3,800 g for 30 minutes.  The concentration of mucoprotein  remaining in the supernatant was 
determined spectrophotometrieally. Comparison  of the results of spectrophotometric deter- 
minations with the weight of dried aliquots indicated that the former were reliable within 
approximately =t=8 per  cent. 
Hemagglutination-inhibition titrations showed uniformly that the inhibitory 
activity was associated with the fraction soluble in phosphate buffer.  Because 
of the large experimental error of the usual twofold dilution technique, a  study 
was made to ascertain whether or not an amount of inhibitor smaller than 50 
per cent of the total was insoluble in phosphate buffer. A photometric apparatus 
developed in  this laboratory was employed in these experiments. The  experi- 
mental error of the photometric technique used was found to be -4-9.5 per cent 
in a  series of 50 duplicate hemagglutination titrations with PR8 and Lee virus. 
The  results are  shown  in Table  II and  indicate that  the  sedimentation  of 
approximately 50 per cent of the total mucoproteins in phosphate buffer had 
no effect on the inhibitory activity of the solution. It appears, therefore, that 76  MUCOPROTEIN  WHICH  REACTS  WITH  VIRUSES 
urinary mucoproteins obtained by salt precipitation in the manner  described 
above are inhomogeneous  and that only about 50 per cent of the total is inhibi- 
tory mucoprotein. When solution of the mucoprotein was carried out at 42°C. 
for 19 hours in the same buffer, 25 per cent loss of activity occurred. Despite this 
loss the active component remained soluble  in phosphate buffer. These results 
indicate that separation of the inhibitory mucoprotein can be obtained by ex- 
traction of dried urinary mucoproteins at 4°C. with 0.025 ~  phosphate at pH 
TABLE II 
Separation of Inhibitory Mucoprotein from  Urinary Mucoproteins with Phosphate Buffer 
dissolved 
at* 
oC. 
4 
Exp.  1 
42 
4 
Exp. 2 
42 
~en Lrlitlgll.- 
tion 
None 
Sup.If 
None 
Sup. 
None 
Sup. 
None 
Sup. 
Mucoprotein 
Concen-  Per cent of 
tration  uncentrifuged 
control 
mg./ml. 
3.2  100 
1.7  53 
3.2  100 
2.5  78 
2.9  100 
1.4  48 
3.0  100 
2.2  73 
Inhibitory activity 
ms.~mr. 
40,320  1.45 
38,910  1.40 
26,115  0.94 
29,640  1.07 
42,890  1.54 
46,560  1.67 
30,990  1.12 
29,790  1.07 
Inhibitory  Per cent of 
Titer~  mucoprotein  luncentrifuged 
__  calculated§  control 
100 
97 
63 
74 
100 
108 
72 
69 
* Solutions in phosphate buffer were held for 19 hours at the temperatures indicated. 
Determined  photometrically with  4  units  of  heated  Lee  virus  and  expressed  as  the 
reciprocal. 
§ Calculated on the basis of an inhibitory activity equal to 0.003 #g. per unit of heated 
Lee virus. 
I[ Supernate after 3,800  g for 30 minutes. 
6.8. As is shown in succeeding papers (34, 35), the inhibitory mucoprotein thus 
obtained appears to be a single homogeneous substance by both electrophoretic 
and ultracentrifugal criteria. 
Chemical Properties.--Results  of chemical  analyses on urinary mucoproteins 
and on the inhibitory mucoprotein are given in Table III.  Comparison of the 
results with values reported  for a  preparation  of semipurified  egg  white in- 
hibitor (22) indicates similarity in the elementary composition of the inhibitory 
mucoproteins obtained from urine and egg white. 
Determinations of reducing sugars  by  Shaffer-Somogyi method and  glucosamine by M. 
Sf~rensen method gave the following results:  x Urinary mucoproteins, preparation A: reducing 
1 Kindly carried out by Dr. M. A. Jesaifis. I.  TAMM AND F.  L.  HORSFALL~ JR.  77 
sugars (after hydrolysis with 1 N HC1 for 14 hours) 19 per cent; glucosamine (after hydrolysis 
with 5 N HC1 for 6 hours) 6.1 per cent. Inhibitory mucoprotein, separated  from preparation 
B: reducing sugars (after hydrolysis with 5 N HC1 for 6 hours) 33 per cent; glucosamine (after 
hydrolysis with 8 N HCI for 6 hours) 9.2 per cent. 
Gottschalk  (38)  reported  that a  dialyzable split-product liberated  from uri- 
nary mucoprotein as a  result of enzymatic action of Lee virus contains isoglu- 
cosamine. The split-product was obtained in a yield of about 1 per cent of the 
mucoprotein used as substrate.  The isoglucosamine would not contribute to the 
glucosamine values  given  above because  this  substance  is  destroyed  on acid 
hydrolysis (38). 
TABLE III 
Results of Chemical A nalyses 
~itrogen ...... 
Earbon. 
[-lydrogen  ..... 
;ulfur. 
Phosphorus. 
~h. 
Urinary mucoproteins 
Preparation  A 
peg Cani 
12.24" 
48.80 
6.65 
3.09~ 
None 
2.99 
Preparation  B 
per ce~l 
11.83" 
46.44 
6.84 
1 82§ 
None 
1.69 
Inhibitory mucoprotein 
(phosphate-soluble  frsctlon 
from preparation B) 
per ceng 
12.62" 
48.62 
6.26 
5.26:~ 
3.75 
All values  are corrected  for moisture  and ash. 
* Micro-Kjeldahl method. 
:~ Parr bomb method. 
§ Carius method. 
Ultraviolet Absorption Spectra.--The ultraviolet  absorption spectrum of uri- 
nary mucoproteins was determined with a Beck,  man model DU spectrophotome- 
ter.  As shown  in  Fig.  1,  the  mucoproteins  g~ve  an  absorption  maximum  at 
=  277 m/z. Beer's law, relating absorption to concentration, was found to hold 
at ),  =  277 m# within the concentration range tested: 0.1 to 1.0 rag.  of muco- 
protein per ml. of 0.025 ~  phosphate  buffer at pH 6.8. The linear relation ob- 
tained  was  used  in determining  the  concentration  of mucoprotein  in various 
preparations.  The validity of Beer's law  was also tested at wavelengths of 245, 
252, 290, and  305 m#, respectively, over a  concentration range from 0.1 to 0.7 
mg. per ml. in phosphate buffer. Linear relations between the negative logarithm 
of transmission  and concentration were found in each case. 
The  ultraviolet  absorption  spectrum  of  the  inhibitory  mucoprotein,  too, 
showed an absorption maximum at a  wavelength of 277 m#  (Fig.  1).  In order 
to establish  whether any differences existed between the absorption spectra of 
urinary mucoproteins and the inhibitory mucoprotein, an aliquot of an uncen- 
trifuged solution of mucoproteins was  diluted so that the concentration corre- 78  MUCOPROTEIN  WHICH  REACTS  WITH  VIRUSES 
sponded to that of the inhibitory mucoprotein solution. As can be seen in Fig. 1, 
the absorption spectra of the diluted urinary mucoproteins and of the inhibitory 
mucoprotein were qualitatively and quantitatively closely similar. These results 
were confirmed in a number of experiments. As shown above, chemical analyses 
of  the  inhibitory  mucoprotein  and  the  urinary  mucoproteins  also  indicated 
chemical  similarity between  the  two in spite of the  fact  that in certain  other 
respects, including  inhibitory  activity and viscosity, the two fractions showed 
striking differences. 
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FIG. 1.  Ultraviolet absorption spectra of urinary mucoproteins and of the inhibitory muco- 
protein. 0.025 ~ phosphate buffer, pH 6.8, was used as solvent as well as blank in each case. 
The concentration of urinary mucoproteins was 0.48 rag. per ml. The concentration  of diluted 
urinary mucoproteins and of the inhibitory mucoprotein  was 0.23 mg. per ml. D  =  optical 
density. 
Infrared Absorption  Spectra.--Infrared  absorption  spectra of urinary muco- 
proteins as well as the inhibitory component were kindly determined by Dr. H. 
Jaffe. Both preparations  showed three significant peaks at wavelengths of 6.5, 
6.1,  and  3.0  u.  The  first  two  peaks  appear  to  represent  ketonic  groupings 
\ 
( C  =  O)  which  may have either  an amidic or acidic structure.  The peak at 
/ 
k  =  3.0 #  corresponds with either --OH  or --NH  groups. 
Stab~ity of the Inhibitory Mucoprotein. Effect of pH.-- Urinary mucoproteins were dissolved 
in a concentration  of 5 rag. per ml. in each of the following buffers: sodium acetate, pH 5.4; I.  TAMM AND  F.  L.  HORSFALL~  JR.  79 
sodium vernonal, pH 8.4, and pH 10.4. In each case the ionic strength was 0.025. The prepara- 
tions were held at 4°C. for 3 days. A control consisting of mucoprotein dissolved in distilled 
water was handled identically. 
The inhibitory activity of the solutions held at pH 5.4 and pH 8.4 was identical with that 
of the control (i.e. 0.016 #g. per unit H. Lee). The solution held at pH 10.4 showed a  slight 
reduction in activity; less than a  twofold decrease. 
The pH stability of the mucoproteins also was tested at 25°C.  The preparation employed 
was prepared by alcohol precipitation and fractionation at pH  3.0 as described previously 
(33). 
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FIc. 2.  Effect of heat on inhibitory activity of mucoprotein. The concentration of mucopro- 
teins in water was 125 #g. per ml., and that of inhibitory mucoprotein in phosphate buffer was 
42.5/zg. per ml. Control titrations showed the activity of mucoproteins in water to be 0.012 
/zg. per unit H. Lee and that of the inhibitory mucoprotein in phosphate buffer to be 0.0083 
#g. per unit H. Lee. 
Aliquots of a  solution containing 1 mg. per ml. in water were diluted 1:4 in each of the 
following  buffers:  boric  acid  buffers,  pH  10.9-8.2;  phosphate  buffer,  pH  7.0;  potassium 
phthalate buffers, pH 6.0-2.0; HC1, 0.1 ~T, pH 1.08. The pH determined before and after mix- 
ing buffer with the mucoprotein did not differ by more than 0.2 pH unit. Controls consisted of 
mucoprotein diluted similarly in each of the buffers, the pH of which had been readjusted to 
6.5.  The solutions were kept at 25°C. for 2.5 hours. The pH was then readjusted with 0.1  N 
HC1 or 0.1 N NaOH to approximately 6.5 and the activity tested. 
It is noteworthy that a visible precipitate appeared at pH 2.0 and 3.0, although none formed 
at pH  1.0 or 4.0.  The precipitates dissolved promptly when the pH  was  readjusted  to  6.5. 
The only specimen which showed decreased inhibitory activity was that at pH 1.08 and the 80  M-UCOPROTEIN WHICH  REACTS  WITH  VIRUSES 
reduction in titer was marked: 99 per cent. From pH 2.0-10.9 no change in activity was ob- 
served. The inhibitory activity of these preparations was 0.012 #g. per unit H. Lee. 
Effect of Heat.--Urinary  mucoproteins dissolved in distilled water and inhibitory mucopro- 
tein in phosphate buffer were heated at 65 ° or 70°C. for various periods of time and the inhibi- 
tory activity then was determined. Fig. 2 gives the results of a  typical experiment. The in- 
hibitor tolerated heating better in phosphate buffer at pit 6.8 than in distilled water at pH 6.3. 
These results indicate that the inhibitory capacity of mucoproteins separated from urine is less 
stable on heating than certain other inhibitors (10, 25). In fact, the purified inhibitory muco- 
protein appeared to b'e more unstable than the original material in urine (33). 
TABLE IV 
Inactivation of Inhibitor by Heat 
Material 
Irine* 
Urinary  inhib- 
itor 
Inhibitor 
Medium 
Water 
0.025 x~ phosphate 
buffer 
Water 
0.025 ~ phosphate 
buffer 
pH 
6.0 
6.8 
6.3 
6.8 
Activity 
512~; 
512~ 
0.oo8§ 
o.oos§ 
Temperature, °C. 
65  ]  70 
Time, mln. 
30  120  30  120 
Inhibitor  inactivated,  per cen# 
0  0  50 
0  0  50 
50  75  >98 
0-50  50  97 
* Dialyzed  against  distilled  water. 
:~ Determined with 8 units of heated Lee virus and expressed as the reciprocal of urine 
dilution. 
§ Determined with 8  units of heated Lee virus and  expressed as/~g,  per unit of virus. 
For purposes of comparison dialyzed urine and inhibitor preparations isolated from urine 
were heated simultaneously under identical conditions and the extent of reduction in activity 
determined. The results given in Table IV show that the inhibitor in urine was inactivated by 
heat more slowly than was the inhibitor in urinary mucoproteins or the purified inhibitory 
mucoprotein. 
During  this  study  virus was  eliminated frequently from mucoprotein-virus mixtures in 
phosphate buffer at pH 6.8 by heating at 65°C. for 30 minutes. The results described above 
show that such heating did not cause appreciable reduction in inhibitory activity. 
The results of the heat inactivation experiments appear of particular interest 
when correlated with viscosity measurements  and with the results of ultracen- 
trifugation studies.  Heating the mucoproteins in water at 70°C. for 30 minutes 
reduced the activity by 75 per cent and the relative viscosity of a  0.1 per cent 
solution from 1.8 to 1.04. After such treatment,  ultracentrifugation  studies  (35) 
showed  the  presence  of  two  components,  whereas  the  unheated  preparation I.  TAMM  AND  F.  L.  HORSX~ALL~ JR.  81 
showed but one. The new component had a lower sedimentation constant and 
was present in greater concentration than the original. 
Physicochemical Properties of  the  Inhibitory  Mucoprotein.--In  succeeding 
papers (34, 35) the results of studies on the inhibitory mucoprotein in the elec- 
trophoresis apparatus and in the ultracentrifuge are described. Both investiga- 
tions showed the substance to be a single homogeneous compound. 
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Viscosity.--The  relation  between  concentration  and  viscosity was  deter- 
mined,  as  described  above,  with  both  urinary mucoproteins and  inhibitory 
mucoprotein.  With  urinary mucoproteins two preparations:  A  and  B,  were 
studied at 37°C. in water. With the inhibitory mucoprotein one preparation was 
examined at 20  ° and at 37°C. in 0.025 M phosphate buffer at pH 6.8. Fig. 3 gives 
the results of representative experiments. The urinary mucoproteins were ex- 
traordinarily viscous. However,  the inhibitory mucoprotein, although giving 
solutions of marked viscosity, did not contribute as much to the total viscosity 82  ~IUCOPROTEIN  WHICH  REACTS  WITH  VIRUSES 
of urinary mucoproteins as did the non-inhibitory fraction. The viscosity of uri- 
nary  mucoproteins  was  measured  in  water  whereas  that  of  the  inhibitory 
mucoprotein was determined in phosphate buffer. When the viscosity of the 
inhibitory mucoprotein was determined in water, somewhat higher values were 
obtained. 
The viscosity data for the inhibitory mucoprotein at 20°C.  (Fig. 3) were used 
to estimate the degree of particle asymmetry in terms of the axial ratio, a/b, of 
an ellipsoid of revolution, where a  =  major axis and b =  minor axis. The rela- 
tion of intrinsic viscosity, defined as the value of the specific viscosity at infinite 
dilution, to axial ratio as formulated by Simha (39) and computed by Mehl et al. 
(40) was used. A value for v which is a function of the axial ratio, was obtained 
by dividing specific viscosity by volume fraction of the solute and extrapolation 
to zero concentration. The results of the computation showed that  v  =  540 
which corresponds to an axial ratio, a/b, of 95. 
Diffusion.--The  diffusion coefficient of the inhibitory mucoprotein at  I°C. 
was kindly determined by Dr. L. G. Longsworth with the aid of the Rayleigh 
interference method (41--43). Although the solute concentration was only 0.24 
per cent and the Kahn-Polson siphoning procedure (44) was used to form the 
initial boundary in the modified Tiselius cell, a zero time correction (45) of 3200 
seconds was  observed, indicating,  possibly, that  the high  viscosity and slow 
diffusion of the material interfered with the formation of a sharp boundary. A 
diffusion coefficient of 1.77 X  10  -8 was obtained by a  procedure corresponding 
to the so called height-area method. On correction to 20  ° this becomes 3.25  X 
10  --~ cm.  2 per sec. : the value used below in connection with the sedimentation 
studies (35). 
The diffusion of the material was not ideal, however, the gradient of refrac- 
tive index being skew with the maximum displaced to the solvent side. If the 
Boltzmann relation (46) is used to  compute a  differential diffusion coefficient 
at the concentration corresponding to the 20 fringes in the pattern, the results 
can be represented approximately by the relation D  =  2 X  10  --8 +  17 X  10-~.C 
(47). Here C is the concentration of the solute in grams of dry weight per 100 
ml. of solution. In view of the probable concentration dependence of the diffu- 
sion coefficient noted here, the provisional nature of the molecular weight and 
shape factor reported below will be recognized. 
The sedimentation constant at zero concentration was found to be 29.5  X 
10  -18 (35) and on the assumption that the specific volume is 0.685 (48-50), the 
molecular weight is computed as 7.0 X  l0  s, and the fifo as 5.71. The axial ratio 
fitting  the  diffusion and  sedimentation  data  was  calculated  on  the  basis  of 
Perrin's equation (51)  and was found to be 202. 
Reacting Proportions of Inhibitory  Mucoprotein  and  Viruses.--To  determine 
the relation between the quantity of inhibitory mucoprotein and the quantity 
of heated virus inhibited, hemagglutination-inhibition titrations were carried I,  TAMXVI AND  ~'.  L.  HORSFALL  1 JR.  83 
out  in  which  the  two  were  varied  with  respect  to  each  other.  The  results  of 
representative experiments are shown in Fig. 4. As can be seen, a  linear relation 
holds over a  wide range when 4 or more units of heated virus is used. However, 
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Flo. 4.  Quantitative relation between inhibitor and virus. Urinary mucoproteins, dissolved 
in 0.025 M phosphate buffer,  pH 6.8, and heated Lee virus, dialyzed against the same buffer, 
were employed in the concentrations indicated. 
TABLE V 
Comparison of Activity of Inhibitory Mueoprotein Relative to Various  Viruses 
Virus 
Lee ............................. 
MB, 3rd egg passage .............. 
PR8 ............................ 
FM1 ............................ 
NA, 2nd egg passage .............. 
"  7th  "  " 
RA, 1st  "  " 
"  5th  "  " 
Swine ........................... 
NDV ............................ 
Mumps ......................... 
Inhibitor activity 
Determined with heated 
virus at 25°C. 
~g.* 
O. 007 
O. 007 
0.0035 
0.007 
O. 0035 
0.007 
0.007 
0.O07 
0.0018 
0.014 
Determined with unheated 
virus at 4'C. 
0.24 
0.028 
0.0035 
0.014 
0.014 
0.014 
0.014 
0.014 
0.0035 
0.45 
O. 007 
* Expressed  as  #g.  per  unit  of  virus. 
:~ Rapid  disagglutination  of  erythrocytes  occurred. 
when less than  4  units  is used,  this relation no longer holds.  Therefore,  when- 
ever quantitatiye comparisons of the inhibitory activity of various preparations 
were made,  4  or more units  of virus was  used. 
In a  series of inhibition titrations with various preparations  of urinary muco- 84  ~COPROTEIN  WHICH  REACTS WITH  VIRUSES 
proteins carried out over many months,  the average activity was found to be 
0.010 gg. per unit H. Lee. After separation of the inhibitory mucoprotein, this 
component showed activity 2.5  to 5  times greater, i.e.,  0.002  to 0.004  ug. per 
unit H. Lee. Comparative titrations with other strains of influenza viruses, as 
shown in Table V, indicated that the inhibitory activity of the substance did 
not vary markedly in respect to the 6  different strains used, 3  of which were 
freshly isolated (1st to  7th egg passages). 
In these tAtrations, 8 units of virus was used. The desired concentration of allantoic fluid 
was determined separately for the heated viruses at 25°C. and for the unheated viruses at 
4°C. Lee, MB, PR8, FM1, NA, and RA viruses were heated at 56°C. for 30 minutes.  Swine 
virus was heated at 52°C. for 30 minutes, NDV at 50°C. for 30 minutes, and mumps virus at 
46°C. for 20 minutes. 
In Table V, comparison is also made between inhibitory activity determined 
with  heated viruses at  25°C.  and  that  determined with untreated  viruses at 
4°C. All activity values fell within the same range with the striking exceptions 
of the low values found with untreated Lee and Newcastle disease viruses at 
4°C. These are discussed below. 
The infectivity tater of Lee virus is approximately E.I.50 =  10  -8.6 with an inoculum of 0.1 
ml. On the basis that at the infectivity end-point there are 10 viral particles in the inoculum 
(52), it can be shown that infected allantoic fluid contains 101°.5 viral particles per ml. The 
hemagglutination tater of such fluid usually is 1,000 indicating that at the end-point there are 
107.5 viral particles per ml. Therefore,  0.003 ~g. of inhibitory mucoprotein  appears to be 
capable of reacting with 10  ~.5 viral particles. The molecular weight of the mucoproteiu  has 
been found to be approximately 7.0 x 106. On the basis of these values, it can be computed that 
the ratio between viral particles and mucoprotein  molecules at the end-point in routine titra- 
tions is of the order of 1:8. It was reported previously that the time of interaction between 
inhibitor and heated virus is a factor of importance in activity measurements  (33). Although 
inhibitor titers showed a rapid rise during the first hour of interaction (the period used in rou- 
tine titratAons as well as in the experiments summarized in Fig. 4), maximal titers were not 
reached until after a 12 hour period of interaction. This was found to be true for inhibitor in 
dialyzed urine as well as for purified inhibitor preparations. Between the 1st and the 12th hour 
the tater increased 4 to 8 times. Therefore, it appears likely that after equilibrium h~ been 
reached theratio between viral particles and inhibitory mucoprotein molecules at the ti+~ation 
~nd-point is close to 1. 
Inactivation  of the Inhibitory Mucoprotein  by Viruses.--In the present study, 
the process of inactivation of the inhibitory mucoprotein by influenza viruses 
was found  to show characteristics compatible with certain kinetic features of 
enzyme reactions. In experiments reported below, the effects of the concentra- 
tion of virus and of mucoprotein on the rate of inactivation are described. The 
capacities of different viruses to inactivate the inhibitory mucoprotein are com- 
pared. A  comparison is also made of the activities of various virus preparations 
stored under different conditions for various periods of time.  In  addition, the 
effect of V. cholerac extract on the activity  of inhibitorymucoprotein is described. I.  TAMM AND  F. L.  HORSFALL~ .JR.  85 
Effect of Concentration of Virus on the Rate of Inactivation  of the Inhibitory 
Mucoprotein.-- 
Mixtures containing 114 #g. of inhibitory mucoprotein and various amounts of Lee virus 
were held for 105 minutes at 37°C. The mucoprotein was dissolved in 0.025 +x phosphate buffer 
at pH 6.8. The virus was dialyzed against and diluted with the same buffer. The reaction was 
stopped by heating at 65°C. as described above and the amount of inhibitor remaining was 
determined with 8 units of heated Lee virus. The control solution of mucoprotein had, both 
before and after the experimental period, an inhibition activity of 0.0035/~g. per unit H. Lee. 
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FIO. 5.  Rate of inactivation of inhibitory mucoprotein as a function of the concentration 
of Lee virus. The amount of mucoprotein in each mixture was 114 ]~g.; the reaction time was 
105 minutes; the temperature 37°C. The amount of inhibitor remaining after the reaction had 
been stopped was measured with heated Lee virus. 
Fig. 5 depicts the results of a representative experiment with viral concentra- 
tion as the variable. As is evident, the first part  of the curve approaches a 
straight line indicating that when conditions were properly chosen, direct pro- 
portional dependence of rate of inactivation on viral concentration was demon- 
strable. With high concentrations of virus,  the changes in rate became pro- 
gressively smaller. The characteristics of the curve are compatible with well 
known features of enzyme kinetics which have been demonstrated repeatedly 
in analogous experiments with various enzymes and substrates (53). 
Inactivation of the Inhibitory  Mucoprotein by Viru~ as a Function of Time.-- 
Mixtures containing 58/~g. of inhibitory mucoprotein and various amounts of Lee virus 
were held at 37°C.  for periods up to 30 minutes. Both reagents were in phosphate buffer, as in 
the preceding experiments. After stopping the reaction by heating, the amount of inhibitor 
was measured with heated Lee virus. The control mucoprotein solution had an activity of 
0.0017 ~g. per unit H. Lee throughout the experiment. 86  MUCOPROTEIN  WHICtt  I~EACTS  WITH  VIRUSES 
In the experiment summarized in  Fig.  6,  the  course of inactivation of the 
inhibitory mucoprotein was followed with three viral concentrations. As can be 
seen, with 256  or 128 units of Lee virus, the reaction seemed to follow essen- 
tially a  logarithmic course indicating a  rapidly decreasing velocity when  the 
concentration of virus relative to the concentration of mucoprotein was high. 
However, at a viral concentration of 64 units, the inactivation appeared to fol- 
low a linear course during the short period of time studied.  Comparison of the 
rates obtained during the initial  phase of the reaction with each quantity of 
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FIG. 6. Inactivation of inhibitory mucoprotein by various amounts of Lee virus as a func- 
tion of time. The amount of mucoprotein was 58/~g.; the temperature 37°C. The residual in- 
hibitor was determined with heated Lee virus. 
virus used supports the conclusion that under proper conditions the rate of in- 
activation is directly proportional to the viral concentration. 
Effect of Concentration  of Inhibitory  Mucoprotein  on Rate of Inactivation  by 
Virus .-- 
Mixtures containing 128 units of Lee virus and 29, 58, or 116/zg. of inhibitory mucoprotein 
were held at 37°C. for periods up to 30 minutes. Both reagents were in phosphate buffer, as in 
the preceding experiments. After stopping the reaction by heating, the amount of inhibitor 
was measured with heated Lee virus. The control mucoprotein solutions had an activity of 
0.0017 #g. per unit H. Lee. 
Fig. 7 shows the results of a representative experiment of this type. It can be 
seen that the rates of inactivation during the initial phase of the reaction were 
closely similar, and thus appear to be independent of the concentration of in- I. TAM[M  AND  F. L. HORSFALL,  JR.  87 
hibitory mucoprotein. The decrease in rate during the later phases of reaction 
became apparent first with the lowest mucoprotein concentration. These find- 
ings also are in agreement with the characteristics of enzyme reactions. 
Comparison of the Enzymatic Activity of Various Viruses Rdative to Inhibitory 
Mucoprotein.-- 
The enzymatic activities  of Lee, PR8,  and  FM1  viruses against  the inhibitory  mucopro- 
tein at 37°C. were compared in the following manner:  128 units of the desired virus was mixed 
with 58/zg. of inhibitory  mucoprotein. In addition,  256 units of Lee virus was mixed with 58 
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FIG. 7.  Rate of inactivation  of inhibitory  mucoprotein by Lee virus as a function of muco- 
protein concentration. The amount of Lee virus was 128 units; the temperature  was 37°C. The 
residual inhibitor was determined with heated Lee virus. 
/zg. of the substance.  The virus preparations  were undialyzed  allantoic fluids diluted  appro- 
priately with 0.025 x, phosphate buffer at pH 6.8. The mucoprotein was dissolved in the same 
buffer. The mixtures were held at 37°C. for periods up to 80 minutes. Aliquots were removed 
at intervals,  heated at 65°C. for 30 minutes and the inhibitory  activity of each aliquot meas- 
ured.  For this purpose each of 3 viruses was employed. All had been heated  at 56°C. for 30 
minutes and a final concentration  of 8 units was used in every instance. The mucoprotein so- 
lution used had, at the beginning of the experiment, an inhibitory  activity of 0.0071/zg. per 
unit H. Lee, H. PR8, or H. FM1, respectively. At the end of the experiment the control solu- 
tion showed no diminution in activity. 
The results of this experiment are given in Fig. 8. As can be seen, Lee virus 
inactivated the mucoprotein more rapidly than  PR8 which had a  more rapid 
action  than  FM1.  However,  the  difference between  the  rates  obtained  with 88  MUCOPROTEIN  WHICH  REACTS  WITH VIRUSES 
256 and  128 units, respectively, of Lee virus was of the same order of magni- 
tude as the difference in the rates obtained with 128  units of Lee or PR8.  Be- 
cause of lack of information regarding the heat  stability of freshly recovered 
strains  of influenza viruses  and  because NDV,  mumps,  and  swine  influenza 
viruses are less heat stable than PR8 or Lee viruses, similar experiments were 
carried out with these agents at 25°C. 
The procedure employed was identical with that described above with the following excep- 
tions: 64 units of each virus was mixed with 58 #g. of inhibitory mucoprotein.  The mixtures 
were held at 25°C. for periods up to 320 minutes. Inhibitory activity was measured wilh 
heated Lee virus. 
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Fio. 8.  Comparison of the rates of inactivation of inhibitory  mucoprotein by various viruses 
at 37°C. 58 #g. of mucoprotein was mixed with either Lee, PR8, or FM1 virus and held for the 
time indicated. After the reaction had  been stopped by heating at 65°C., the amount of in- 
hibitor remaining in each mixture was measured with heated Lee, PR8, and FM1. 
The results of these experiments are shown in Fig. 9. As can be seen, differ- 
ences in the rates of inactivation by certain of the viruses appear definite. At 40 
minutes Newcastle disease and Lee viruses had inactivated 87 and 75 per cent, 
respectively, of the inhibitory mucoprotein,  whereas  after 320  minutes  there 
was no  demonstrable inactivation by either swine or mumps  virus under  the 
experimental conditions employed. 
Comparison  of the Enzymatic Acti:ity of Viruses  Stored under Different  Con- 
ditions.--In  the  inactivation  experiments  described  above,  freshly  dialyzed 
viral  preparations  or  undialyzed  allantoic fluids,  which  had  been  stored  at I. TAMM  AND  Y. L. HORSFALL,  JR.  89 
-65°C.,  were  used.  In  the present experiments,  various preparations of Lee 
or PR8 virus which had been stored for different periods at either 4 or -65°C. 
were employed. 
In each case 128 units of each virus preparation and 58 #g. of inhibitory mucoproteins were 
used. To obtain the desired concentration of virus, the preparations were diluted with 0.025 
M  phosphate buffer at pH 6.8. The mixtures were held at 37°C. for 20 or 60 minutes. Aliquots 
removed after these intervals were heated at 65°C. for 30 minutes and inhibition titrations 
were performed with 4 units final of heated Lee virus. The control mucoprotein  solutions had 
an activity of 0.0035 ~g. per unit H. Lee throughout the experiment. 
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Fie. 9.  Comparison of the rates of inactivation of inhibitory mucoprotein by various viruses 
at 25°C. 58 ~g. of mucoprotein was mixed with 64 units of the viruses indicated. NA represents 
7th egg passage, 1951 influenza A virus. MB represents 3rd egg passage, 1950 influel~a B virus. 
In each instance the amount of inhibitor remaining in the mixture was measured with heated 
Lee. 
Table VI  shows  the stability of influenza virus enzymes active against in- 
hibitory mucoprotein  on  storage  under  various  conditions.  Freshly dialyzed 
allantoic fluids and undialyzed fluids stored at -65°C. for as long as 20 months 
were equally active. Dialyzed Lee virus which had been stored at 4°C. for 3  to 
6 months showed a definite loss in activity without an accompanying reduction 
in  hemagglutination  titer.  Dialyzed PR8  virus,  after  storage  at  4°C.  for  12 
months showed markedly reduced activity although the hemagglutination titer 
was within the usual range. Thus, on prolonged storage at 4°C., both Lee and 
PR8 appear to become similar to viruses which have been heated at 56°C. for 
30  minutes in that they lose much  of their enzymatic activity but retain the 
ability to agglutinate red blood cells. 
Effecf of V. eholerae Extract on the Inhibitory Mucoprotein.--Inhibitory  muco- 
protein in phosphate  buffer was mixed with an  equal  volume  of  V.  cholerae 
extract. The mixture was held at 37°C. for different periods of time and then 
heated at 65°C. for 30 minutes. The remaining inhibitor activity was measured 
with  heated Lee virus.  It was  found that 99 per cent of the inhibitor was in- 90  MUCOPROTEIN WHICH REACTS WITH VIRUSES 
activated within 1 hour.  The  concentration  of mucoprotein  used  was  72  gg. 
per ml., and the control titer of the substance mixed with heated  V.  cholerae 
extract (65°C. for 30 minutes) was 0.0029 #g. per unit H. Lee virus. 
Properties of the Inhibitory  Mucoprotein Altered by  Viral Action.--The  elec- 
trophoretic and ultracentrifugal characteristics of the inhibitory mucoprotein 
altered by influenza virus are described in succeeding papers (34, 35). No change 
TABLE VI 
Effect of Storage on the Enzymatic  Activity  of Lee and PR8  Viruses 
Virus preparation  used as enzyme*  Time of enzymatic  action at 37°C. 
Storage 
Virus 
Dialyzed, 0.1 
phosphate buf- 
fer pH 7.14 
Lee  Dialyzed, 0.025 
M  phosphate 
buffer pH 6.8 
Undialyzed 
Dialyzed, 0.1 ~s 
phosphate buf- 
PR8  fer pH 7.14 
Undialyzed 
Tem°  1 
pera- /  Time 
ture 
T-- 
....  1-- 
4  6 days 
"  6 mos. 
4  6 days 
"  3 mos. 
-6,5  60days 
2  mos. 
I 
4 
I 
I 
--65  20 mos. 
Hemag- 
Jglutination 
i  tlter~/ 
512 
1024 
512 
1024 
512 
1024 
1024 
1024 
20 mln.  i  60 rain. 
i 
Inhibitor I] Inhibitor ] Inhibitor  Inhibitor 
inacti-  activity  inacti-  activity I  vated  ~  vated 
--  I 
~g.  per cent 
0.0035  0 
0.056 
0.014 
0.056 
0.014 
0.11 
0.22 
0.0035 
0.026 
94 
75 
94 
75 
97 
98.4 
I 
87.5 
#g.  ] per cent 
0.0035  0 
>1.8  >99.8 
0.22  98.4 
>1.8  >99.8 
0.11  97 
>1.8  >99.8 
>1.8  >99.8 
0.007  50 
0.23  98.4 
* 128 units of each viral preparation was used. 
:~ Expressed as reciprocal of dilution. 
in  viscosity of  the  altered  substance  was  observed in  repeated  experiments. 
This finding correlates well with the results of studies in the ultracentrifuge (35) 
which showed no evidence of extensive splitting or aggregation of the altered 
mucoprotein molecules. 
Beard et al., working with ovomucoid, observed both a  decrease in viscosity 
(54) and a  decrease in sedimentation constant  (55) after alteration of their in- 
hibitor by influenza viruses. It should be pointed out that the inhibitor in egg 
white has not been obtained in the form of a  single homogeneous component. 
The  best preparations  showed  three  components  on  electrophoresis and  the 
largest of these was found to be inactive (56). I.  TAMM AND F.  L.  HORSFALL, JR.  91 
The  ultraviolet  and  infrared  absorption  spectra  of  the  altered  inhibitory 
mucoprotein were found not to differ appreciably from those of the native sub- 
stance. Experiments have failed to show differences in the precipitability, with 
sodium chloride,  of the altered mucoprotein. 
The results obtained in this study correlate satisfactorily with the findings of 
Gottschalk (38)  who recovered a dialyzable split-product in a yield of no more 
than about 1 per cent from urinary mucoprotein which had been treated with 
Lee virus.  The nature  of this split-product has been extensively studied  and 
Gottschalk has ascribed an isoglucosamine structure  to the compound which 
he has defined as N-l-deoxy-l-ketose aminoacid (or peptide). 
Activity of Inhibitory Mucoprotein against  Untreated or Heated  Viruses.--Pre- 
vious observations, made with  the  urinary  inhibitor  (33)  and  representative 
strains of influenza, mumps, and Newcastle disease viruses, confirmed and ex- 
tended  results  obtained  with  inhibitors  derived  from other  sources  (10,  57). 
It was found  that  at  room temperature inhibition  titers were low when  un- 
treated  viruses were  used.  The  only  two  untreated  viruses which  gave high 
inhibition  titers at room temperature were swine influenza and mumps (33). 
The  hypothesis has been entertained  that  untreated  viruses which  give low 
inhibition titers at room temperature are enzymatically active against mucoid 
inhibitors and that inactivation takes place while the titration is in progress. In 
the enzymatic experiments reported above, it was shown that swine influenza 
and mumps viruses were the only viruses among those tested which were in- 
capable of reducing the inhibitory capacity of urinary mucoprotein in 5 hours 
at room temperature. 
Assuming that  at 4°C.  the rate of enzymatic activity of viruses is greatly 
reduced, it would be expected that untreated viruses should be, to a high degree, 
inbibitable by urinary mucoprotein at this temperature. It was shown in Table 
V that this was generally the case but that Lee and Newcastle disease viruses 
afforded striking exceptions. A similar observation pertaining to Lee virus was 
made by Anderson  (17). 
The  following experiments were done  to  determine the mechanism of this 
peculiar reaction with Lee virus:- 
In Experiment 1 various amounts of mucoprotein were mixed at 4°C. with 16 units of un- 
treated Lee virus, held for 1 hour, and RBC added. No inhibition of hemagglutination oc- 
curred when the quantity of mucoprotein was as much as 3.5 #g., i.e., 0.22/zg. per unit of virus. 
In Experiment 2, 40 units of the same unheated virus preparation was mixed at 4°C. with 3.5 
#g. of mucoprotein and held for 1 hour. The mixture was then heated at 65°C. for 30 minutes 
and the inhibitory activity of the mucoprotein determined with heated Lee virus. There was 
no reduction in the activity of the inhibitor even though the ratio between mucoprotein and 
virus in the original mixture was 0.085/zg. per unit, i.e., 2.6-fold less than in Experiment 1. 
It appears that these seemingly conflicting results are dependent  upon the 
difference in the way in which inhibitor was measured in the two experiments. 
In Experiment  1 the activity of the inhibitor was determined with untreated 92  MUCOPROTEIN  WHICH  REACTS  WITH  VIRUSES 
virus. On the other hand, in Experiment 2, after heating the mixture at 65°C., 
the activity of the inhibitor was  determined with heated virus in  the usual 
manner. 
A modified hemagglutination-inhibition experiment was devised in order to 
determine whether, under the conditions of Experiment 1,  the low inhibition 
titer with untreated virus at 4°C. was due to inactivation of the inhibitor. 
Mter holding dilutions of inhibitor with 16 units of untreated Lee virus at 4°C. for 1 hour, 
the mixtures were heated at 65°C. for 30 minutes and then cooled to 4°C. A constant amount~ 
16 units, of heated Lee virus was added to all tubes, and after 1 hour at 4°C. RBC were added. 
It was found that the activity of the inhibitor so treated was equal to that of the control, 0.007 
/zg. per unit H. Lee, which had been held with heated Lee virus under the same conditions. 
These results show that low inhibitory titers obtained with untreated Lee 
virus at 4°C. are not due to inactivation of the inhibitor. Moreover, they sug- 
gest  that  the  low  inhibitory activity at  this  temperature may be  due  to  a 
greater affinity of untreated Lee virus for chicken erythrocytes than  for in- 
hibitory mucoprotein; that after heating the virus the relationship is changed 
so that affinity for mucoprotein is increased. This point of view is in agreement 
with the hypothesis offered by Anderson et al. (58). 
The question can be raised whether or not untreated Lee virus combines at 
all with inhibitory mucoprotein at 4°C.  An affirmative answer was obtained 
in an experiment in which untreated Lee virus and inhibitory mucoprotein were 
mixed and held at 4°C. for 1 hour. The mucoprotein was then precipitated with 
0.58 M NaC1 and removed by centrifugation. Controls showed that such a pro- 
cedure did not reduce the virus titer in the absence of the mucoprotein. How- 
ever, in the presence of 0.28 #g. of mucoprotein per unit of Lee virus, 92 per 
cent of the virus was precipitated with the mucoprotein indicating that the two 
were associated at 4°C. 
Effect of Mucoprotein  on the Infectivity  of Influenza  Viruses.--The  effect of 
urinary mucoprotein on the infectivity of Lee and RA (lst egg passage) strains 
of influenza B and A viruses, respectively, as well as swine influenza virus, was 
investigated in the chick embryo. The quantity of mucoprotein, the time it was 
injected, the amount of virus inoculated, and the duration of incubation were 
varied. No effect on the infectivity of Lee virus was observed when up to 300 
/~g. of urinary mucoproteins was injected per embryo with various quantities of 
virus, the dilutions of virus having been prepared in buffered saline. 600/~g. per 
embryo reduced the infectivity end-point of Lee virus from 10  -7"5 to 10  -e. The 
infectivity of RA virus was not affected by 14.5 #g. of inhibitory mucoprotein 
per embryo. However, when dilutions of virus were prepared in the inhibitor 
solution, 300 ~g. of inhibitor per embryo reduced the infectivity end-point of 
Lee virus from 10  -~'5 to  10  -5"~, and a  reduction of greater than  105-fold with 
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to combination of the virus and mucoprotein while the dilution series was being 
prepared. 
When  200 tzg.  of inhibitory mucoprotein was injected  per  embryo  2  hours 
before Lee virus, a  reduction in infectivity titer of the order of 1 to 2 log units 
was  observed  in  three  different  experiments.  In  addition,  hemagglutination 
titrations of individual allantoic fluids from eggs which had received mucopro- 
tein showed 4- to 16-fold lower titers than allantoic fluids from eggs which had 
not  received  mucoprotein.  However,  hemagglutination-inhibition  titrations 
showed that the apparent low virus yields were associated with  demonstrable 
inhibitory activity in the infected allantoic fluids. Infected allantoic fluids from 
control eggs showed no inhibitory activity, as was found also by other workers 
(10, 59). 
In view of the ability of influenza viruses to inactivate the inhibitory  capac- 
ity of mucoprotein,  it is not surprising  that the substance  showed no  marked 
effect on infectivity  titrations  with  these  agents  in  the  chick embryo  except 
when dilutions  of virus were made ill inhibitor solution. 
Anligenic _Properties of the Urinary Mucoprotein.--Antibodies  were prepared 
in rabbits  against  urinary mucoproteins as well as against  the inhibitory mu- 
coprotein. 
20 mg. of urinary mucoproteins or 10 mg. of inhibitory mucoprotein was injected intrave- 
nously per rabbit in divided doses over the course of several weeks and blood collected 2 weeks 
after the last injection. 
Precipitation  Tests.--The  capillary  precipitation  technique  (60)  was  em- 
ployed. Experiments with urinary mucoproteins and the inhibitory mucoprotein 
showed that 2 to  10/~g. per ml. of either was capable of yielding  precipitates 
when mixed with antiserum against  urinary mucoproteins. Mter  treatment  of 
either  mucoprotein  preparation  with  V.  cholerae  extract,  which  resulted  in 
greater  than  99 per  cent loss of inhibitory  capacity,  the altered mucoprotein 
still gave precipitates with antiserum against native urinary mucoproteins. In 
experiments  with  antiserum  against  the  inhibitory  mucoprotein  as  little  as 
0.04 ~g. per ml.  of inhibitory mucoprotein was sufficient to give precipitates. 
Inactivation of inhibitory mucoprotein by V. cholerae extract did not alter its 
capacity to give precipitates  with the homologous antiserum. 
Effect of Antiserum on Inhibitory Capacity.-- 
Dilutions of normal rabbit or antisera against urinary mucoproteins were mixed with a con- 
stant amount of inhibitory  mucoprotein.  The sera  used  had  been absorbed  with  chicken 
erythrocytes  to remove agglutinins against  such  R.BC and  the serum inhibitor was  inacti- 
vated by treatment with PR8 virus and subsequent  heating  at 65°C. for 30 minutes.  Ten 
minutes  after  the mixtures  were prepared,  8 units  of heated  Lee virus  was added  and  1 
hour later chicken erythrocytes were added as in the usual hemagglufination-inhibition  "fst. 
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Immune rabbit serum, at a dilution of 1:80, was found to be capable of pre- 
venting the inhibitory effect of 1.2 #g. of inhibitory mucoprotein. In terms of 
control titrations of inhibitor and virus, this quantity represented 8 times the 
amount of inhibitor required to inhibit the viruspresent in the mixture (8 units 
final). 
Although antibodies against the inhibitory mucoprotein are capable of ob- 
literating inhibitory activity, there is no reason to suppose that such antibodies 
combine with those groupings of the molecule which react with viruses. The fact 
that mucoprotein altered by the action of V. Cholerae extract reacts with anti- 
bodies against the native substance in undiminished degree suggests that other 
groupings are involved. 
In other experiments no evidence was obtained that antibodies against uri- 
nary mucoproteins were capable of agglutinating either chick or human eryth- 
rocytes. Moreover, such antibodies did not prevent infection of the chorioal- 
lantoic membrane with swine influenza virus. 
DISCUSSION 
The finding that mucoproteins isolated from human urine by means of pre- 
cipitation with sodium chloride yield, on extraction with phosphate buffer, a 
fraction which consists of a single homogeneous substance, according to electro- 
phoretic (34) and ultracentrifugal (35) criteria, is of interest because this frac- 
tion appears to be responsible for all the hemagglutination-inhibiting activity 
of such urine. The methods employed in isolation and purification are both 
simple and gentle, and the product obtained is characterized by high molecular 
weight, high degree of molecular asymmetry, and biological activity of a very 
high order.  A  homogeneous substance which reacts with influenza, mumps, 
and Newcastle disease viruses thus becomes available. At the present time the 
ability of this substance to inhibit hemagglutination by heated viruses is the 
most accessible  of its biological properties and one which can be measured with 
some precision. In causing inhibition of hemagglutination, mucoprotein mole- 
cules appear to react with influenza viral particles in a proportion which is close 
to  1:1. This correlates well with the estimate of Friedewald and Pickels (52) 
that the ratio of influenza viral particles to red blood cells at the 50 per cent 
hemagglutination end-point is approximately 1. 
Of chief interest is the finding that inhibitory mucoprotein appears to act 
as a  substrate for enzymes associated with irrfluenza, mumps, and Newcastle 
disease viruses. A detailed and quantitative study of influenza virus-mucopro- 
tein interaction has provided further evidence in favor of the hypothesis that 
these viruses are capable of altering inhibitory mucoprotein in an enzymatic 
manner. The combined evidence emerging from this study, the work reported 
in  succeeding papers  (34, 35),  and  Gottschalk's investigations  (38) indicate 
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mumps, and Newcastle disease viruses, brought about by the action of enzymes 
associated with these agents, is not due to extensive alteration in the molecular 
structure of the substance, but is the result of the splitting off of a small portion 
of the molecule. 
Certain  features  of  experiments  on  enzymes  associated  with  influenza, 
mumps, and Newcastle disease viruses require comment. Among these are the 
following: the number and nature of the enzymes are not known; the uncer- 
tainties involved in estimating the concentration of enzymes are marked, mak- 
ing  comparison of  the activity of different preparations  unreliable;  and  the 
enzymatic action is  measured in  terms  of  loss  of inhibitory activity of the 
mucoprotein which, with conventional techniques, does not permit measurement 
of small changes. The problem of the purity of preparations of animal viruses 
bears directly on enzymatic experiments with these agents. Although there is 
strong evidence that enzymatic activity against inhibitory mucoprotein is as- 
sociated with the viral particles, it has been shown (61) that highly purified 
preparations of influenza virus contain host material in considerable amount 
and, as a consequence, could contain enzymes derived from infected host cells. 
There is,  however, no evidence that normal allantoic fluid or chorioallantoic 
membrane from embryonated eggs contains enzymes capable of inactivating 
inhibitory mucoprotein  Reservations similar to those stated above have been 
expressed previously by other workers (16,  17). 
SUMMARY 
A mucoprotein, present in normal human urine, has been isolated and ob- 
tained in a state of a high degree of purity. A number of the biological, chemical, 
and physicochemical properties of the substance have been studied. From the 
results obtained in the present investigation and those reported in succeeding 
papers  (34, 35) it appears that the mucoprotein has a  high molecular weight, 
i.e.,  of the order of 7.0 N  108, consists of thread-like molecules which have axial 
ratios of approximately 100, and is specifically antigenic. This substance, which 
appears to be free of contaminating material, possesses in extraordinary degree 
the capacity to react with influenza, mumps, and Newcastle disease viruses. 
At  equilibrium,  with influenza virus,  the minimal amount of the  substance 
capable  of giving  a  demonstrable  reaction with  one  hemagglutinating unit 
of virus appears to be about 0.0003 ug. The mucoprotein is altered by prepara- 
tions of influenza viruses and its capacity to react with these agents or others is 
lost.  The  kinetics  of  the  inactivation  process  brought  about  by  influenza 
viruses is in accord with those of well known enzyme-substrate systems. With 
the exception of the capacity to react with viruses, altered mucoprotein did not 
differ from the native substance relative to any of the properties examined in 
the present study. That certain physicochemical properties of the altered muco- 
protein are different from those of the native substance is demonstrated in suc- 
ceeding papers  (34, 35). 96  MUCOPROTEIN  WHICH  REACTS  WITH  VIRUSES 
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